Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in China
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1720
https://www.valueinhealthjournal.com/article/S1098-3015(15)01777-5/fulltext
Title :
Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01777-5&doi=10.1016/j.jval.2015.03.1720
First page :
A295
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
1199